Curis, Inc. (CRIS) Reports In-Line Q1 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Curis, Inc. (CRIS) Reports In-Line Q1 Loss

Curis' (CRIS) Q1 Results Flat; Erivedge Growth, Pipeline Remain in Focus - Roth

May 8, 2014 2:18 PM EDT

Roth Capital comments on Curis, Inc. (Nasdaq: CRIS) following the company's Q1 report, which was out ahead of the bell Thursday. Briefly, Curis posted an in-line loss of 8 cents per share.

Analyst Joseph Pantginis commented, After the FDA removed the partial clinical hold on the Phase I CUDC-427 monotherapy study in March, CRIS is preparing to re-open the study under the amended protocol. CRIS plans to initiate... More